Results showed that, CASC15, one lncRNA that was firstly identified as a tumor suppressor in neuroblastoma but was later reported to play an oncogenic role in melanoma [21, 22], was significantly upregulated in NSCLC compared with matched adjacent normal tissues (p < 0.001, Fig. 1a). Here, CASC15 is linked to melanoma.